Leerink Swann Lowers Estimate for Illumina's Q1 Revenues, EPS
April 12, 2011
Leerink Swann Lowers Estimate for Illumina's Q1 Revenues, EPS
The investment firm lowered its estimates from levels predicted last week to reflect lost consumables sales on its older next-gen sequencing platforms and softer microarray consumables sales sequentially.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.